Zoetis (ZTS) Non-Current Deferred Tax Liability (2012 - 2026)
Zoetis' (ZTS) quarterly Non-Current Deferred Tax Liability came in at $122.0 million in Q2 2026, down 21.79% year-over-year from $156.0 million in Q2 2025, and down 6.15% quarter-over-quarter from $130.0 million in Q1 2026.
Analysis
Zoetis (ZTS) Non-Current Deferred Tax Liability (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Non-Current Deferred Tax Liability for 15 consecutive years, with $122.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Deferred Tax Liability fell 21.79% year-over-year to $122.0 million in Q2 2026; TTM through Jun 2026 was $122.0 million, a 21.79% decrease from a year earlier, with the FY2025 full-year figure at $137.0 million, down 17.96% from the prior year.
- Non-Current Deferred Tax Liability was $122.0 million for Q2 2026 at Zoetis, down from $130.0 million in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $287.0 million in Q1 2022 and troughed at $121.0 million in Q2 2023.
- A 5-year average of $167.8 million and a median of $151.5 million in 2025 frame the typical range for Non-Current Deferred Tax Liability.
- Across the five-year window, Non-Current Deferred Tax Liability tumbled 55.84% in 2023 and surged 44.63% in 2024, its largest moves.
- Over 5 years, Non-Current Deferred Tax Liability stood at $142.0 million in 2022, then increased by 2.82% to $146.0 million in 2023, then increased by 14.38% to $167.0 million in 2024, then decreased by 17.96% to $137.0 million in 2025, then decreased by 10.95% to $122.0 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $122.0 million (Q2 2026), $130.0 million (Q1 2026), and $137.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 42.23 Bn | 42.03 Bn | 779.09 Mn |
| 2 | Zoetis | 31.39 Bn | 29.72 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 12.21 Bn | 11.68 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.55 Bn | 1.47 Bn | 134.40 Mn |
| 5 | Immucell | 89.91 Mn | 81.05 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 76.30 Mn | 77.22 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 122.00 Mn |
| Mar 31, 2026 | 130.00 Mn |
| Dec 31, 2025 | 137.00 Mn |
| Sep 30, 2025 | 147.00 Mn |
| Jun 30, 2025 | 156.00 Mn |
| Mar 31, 2025 | 161.00 Mn |
| Dec 31, 2024 | 167.00 Mn |
| Sep 30, 2024 | 172.00 Mn |
| Jun 30, 2024 | 175.00 Mn |
| Mar 31, 2024 | 136.00 Mn |
| Dec 31, 2023 | 146.00 Mn |
| Sep 30, 2023 | 160.00 Mn |
| Jun 30, 2023 | 121.00 Mn |
| Mar 31, 2023 | 131.00 Mn |
| Dec 31, 2022 | 142.00 Mn |
| Sep 30, 2022 | 256.00 Mn |
| Jun 30, 2022 | 274.00 Mn |
| Mar 31, 2022 | 287.00 Mn |
| Dec 31, 2021 | 320.00 Mn |
| Sep 30, 2021 | 291.00 Mn |